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A B S T R A C T
Catheter ablation is highly successful and may be considered as the first line treatment 
in all symptomatic idiopathic forms of ventricular tachycardia (VT). Also ablation 
plays an important role in recurrent VTs associated with structural heart disease and 
relatively preserved left ventricular ejection fraction (>35%) and/or bundle branch 
reentry VT. It also constitutes the preferable treatment modality in incessant VTs of 
any origin and in patients with implantable defibrillator (ICD) devices who present 
with recurrent VTs and/or an electrical storm leading to multiple ICD shocks
Catheter ablation appears to improve arrhythmia control in about two thirds of pa-
tients with structural heart disease and mappable VTs. Novel substrate and/or non-
contact mapping techniques suggest that even hemodynamically unstable VTs and/or 
VTs of multiple morphologies can be successfully ablated. As the ablation method is 
not curative and there remains the risk of dying suddenly in patients with depressed 
left ventricular ejection fraction, the majority of patients with VT associated with 
structural heart disease also receive an ICD.
I N T R O D U C T I O N
Management of ventricular tachycardias (VTs) remains a continuing challenge 
even in the era of implantable cardioverter-defibrillators (ICDs). Although successful 
in terminating VT, these devices do not prevent episodes of arrhythmia. In respect, 
catheter ablation offers a substantial potential to control and cure VT.
Based on ECG morphology, VTs are described either polymorphic or monomor-
phic.1 Until recently, only monomorphic VTs have been a subject to catheter ablation. 
Our group reported probably one of the first cases of successful catheter ablation of 
focus triggering polymorphic VT and/or ventricular fibrillation.2 More recently, this 
approach has been described in a collaborative report by Haissaguerre et al.3 Trig-
gering foci originate often from Purkinje fibers of the left ventricular septum and can 
be identified as monotopic ventricular ectopy, usually with a short coupling interval. 
Monomorphic VTs are characterized by a constant morphology of the QRS complex, 
indicating the same sequence of ventricular activation.
Arrhythmia may originate either from a focal source or be a result of reentrant 
activation within the circuit, usually associated with structural substrate.1 The 
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mechanism of focal VTs comprises abnormal automaticity, 
triggered activity and/or microreentry circuit. Importantly, 
the QRS morphology suggests the probable arrhythmogenic 
region. A left bundle branch block (LBBB) configuration in 
precordial lead V1 implies an origin in the right ventricle or in 
the interventricular septum. On the contrary, a right bundle 
branch block (RBBB) appearance indicates origin in the left 
ventricle. Inferiorly directed frontal plane axis reflects an 
origin in the superior aspect of the left ventricle. Superior 
frontal plane axis suggests origin in the inferior wall of the 
left or right ventricle. Predominant R waves in precordial lead 
V4 favours origin near the base of the heart, while dominant 
S waves suggest rather apical site.
Ventricular tachycardia occurring in subjects with appar-
ently healthy heart (i.e. without identifiable structural heart 
disease) is referred to as “idiopathic” and is usually focal in 
origin. On the other hand, VT associated with myocardial 
scars is typically re-entrant. Rarely, VT in these patients could 
be focal in origin. Patients with nonischemic cardiomyopathies 
are prone to development of bundle-branch reentry VT.
I D I O pA T h I C  v T
Ventricular tachycardia in subjects without structural 
heart disease accounts for a minority of all VTs. Prognosti-
cally, these arrhythmias are considered benign and catheter 
ablation is indicated in symptomatic cases. High success rate 
of catheter ablation reflects focal origin of idiopathic VTs.4 
Despite the fact that the focus can be situated in any region of 
the ventricles, two locations prevail in clinical arena.
Idiopathic right ventricular outflow tract VT is the most 
frequent entity among idiopathic VTs. The mechanism of this 
arrhythmia is most probably triggered activity.4,5 The site of 
origin in the outflow tract of the right ventricle leads to a spe-
cific ECG pattern of a LBBB with inferior frontal plane axis. 
This arrhythmia occurs either as a repetitive or paroxysmal VT 
and is frequently triggered by adrenergic stimulation. Catheter 
ablation has become first-line therapy in this condition in the 
majority of cases. It is guided by activation sequence map-
ping (i.e. searching for the earliest site of activation during 
tachycardia) and/or by pace-mapping (i.e. reproduction of 
VT morphology through pacing at the site of origin). The 
success rate of catheter ablation reaches approximately 85%. 
Inability to induce the arrhythmia and/or its epicardial or deep 
septal location usually account for failures. In some patients, 
catheter ablation could be performed from the pulmonary or 
aortic cusp and/or from a subaortic region.6 In such cases, R 
wave transition occurs in V1-V3.
Idiopathic left ventricular fascicular tachycardia originates 
in calcium channel-dependent tissue of the Purkinje fibers on 
the interventricular septum.4,7 Reentry involving the posterior 
or anterior fascicle is considered the mechanism of this ar-
rhythmia. The site of origin corresponds to QRS morphology. 
Typically, a RBBB configuration with a superior (or inferior) 
frontal axis can be recorded. Catheter ablation is successful 
in approximately 90% of cases and is guided by mapping of a 
discrete Purkinje potential preceding the QRS complex dur-
ing VT.7 Inability to ablate this arrhythmia reflects catheter-
caused pressure trauma to the focus.
v T  A S S O C I A T e D  w I T h  S T R U C T U R A l  h e A R T 
D I S e A S e
These arrhythmias are caused by reentry involving a region 
of ventricular scar of different origin.1 The most frequent 
cause of the scar is previous myocardial infarction. Other 
causes include arrhythmogenic right ventricular dysplasia, 
nonischemic cardiomyopathies, ventriculotomies after surgery 
for congenital heart disease, sarscoidosis and others. Dense 
scars create anatomical barriers and intercellular fibrosis 
decreases cell-to-cell coupling, resulting in slow conduction. 
These conditions are known to promote reentry. During VT, 
the morphology of the QRS complex reflects the location of 
the exit from the protected isthmus of slow conduction. The 
timing of the local activation corresponds to the beginning of 
the QRS complex and the wavefront then propagates through 
the surrounding myocardium towards the entrance site of the 
isthmus (outer or inner loop). Configuration of the individual 
circuit varies based on arrangement of the scar tissue. Often, 
one isthmus is shared by several circuits with different exits. In 
such cases, several VT morphologies can occur spontaneously 
and/or can be induced in the electrophysiology laboratory. 
In the majority of postinfarction scars, the isthmuses are 
localized in the subendocardial region and thus, accessible to 
catheter ablation. Until recently, their identification required 
detailed mapping during tolerated tachycardia. Entrainment 
mapping was used to confirm participation of the isthmus in 
the circuit.8 Provided the pacing site is within the protected 
isthmus, pacing at cycle length 20-50 ms shorter speeds up VT 
without any change in QRS morphology (concealed entrain-
ment) and the post-pacing interval (i.e. the first cycle after 
termination of pacing) equals tachycardia cycle length. At 
the same time, stimulus to QRS interval during entrainment 
pacing equals spontaneous interval between local electrogram 
in mapping catheter and the beginning of the QRS during 
VT. More recently, the so-called substrate mapping can be 
used to describe morphological substrate for VT in sinus 
rhythm using an electroanatomical mapping system.9 Pacing 
manoeuvres can be used to reconstruct re-entrant circuit, 
analyzing stimulus-to-QRS intervals in different locations of 
the presumed isthmus (isthmuses) and looking for perfect or 
near-perfect match in ECG morphology with ECG during VT. 
Another alternative for mapping and ablation is non-contact 
mapping that could be used in unstable VTs to reconstruct 
the zone of slow conduction during one cycle of arrhythmia.10 
Rarely, arrhythmogenic foci or critical isthmuses are localized 
epicardially. Therefore, a technique of epicardial mapping 
and ablation through a direct intrapericardial approach has 
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been described.11
As ablation lesions produced with a standard 4-mm tip 
catheter are limited in size, irrigated-tip catheters are prefer-
ably employed for this purpose.12 Still, a line of radiofrequency 
lesions is often necessary across a region of the circuit and/or 
its exit to ablate successfully all inducible VTs or at least 
clinical ones. This reflects another problem of inducibility of 
several different VT morphologies in an individual patient. 
Spontaneously occurring VTs are then considered as “clinical 
VTs”, while other inducible VTs are referred to as “non-clini-
cal VTs”. However, some of the “non-clinical” VTs may recur 
after successful ablation of a “clinical” VT.
Postinfarction VT
Hemodynamically tolerated VT allows detailed mapping 
(including entrainment mapping) during arrhythmia and thus, 
precise description of the reentrant circuit. The success rate 
of catheter ablation of mappable VT has been reported in the 
range of 70-75%, with a recurrence rate of 10-40%.13,14 Others 
targeted all inducible VTs 16-18 and achieved noninducibility in 
approximately 30% of patients, and almost 50% of subjects had 
successful modification of the substrate with noninduciblity of 
targeted VTs. Almost two thirds of patients were arrhythmia 
-free during long-term follow up.
The patient with untolerated VT is a particularly dif-
ficult problem. The so-called substrate mapping seems to 
provide a solution. The procedure is based on the ability of 
electro-anatomical mapping to localize and quantify abnor-
mal electrograms and scar tissue in a 3D reconstruction of 
endocardial surface of the left or right ventricle.9,18 The areas 
of scar are defined as sites with low voltage amplitudes <0.1-
0.5 mV, while normal tissue has the voltage of electrograms 
>1.5 mV. In addition, electrical nonexcitability can be used to 
identify “dense scars” as areas without pacing capture at 10 
mA. This allows identification of relatively narrow isthmuses 
of slow conduction even within relatively large regions of very 
low voltage (<0.5 mV). At the same time, pacing at each site 
allows analysis of 12-lead ECG as well as interval stimulus-
to-QRS interval. This approach provides detailed description 
of the substrate with an exit site and the central zone (Figure 
1). Radiofrequency (RF) energy could be applied across the 
exit region, some target also late potential areas and/or con-
nect areas of dense scars to eliminate all potential conduction 
channels. Pacing is used again after each RF energy applica-
tion to assess lesion completeness. Our experience and that 
of others suggest that these approaches may eliminate all VTs 
in 60-80 % of cases.19-21 However, more data from prospective 
trials are needed.
It remains unknown whether successful catheter ablation 
of post-infarction VT may result in a complete cure. Patients 
often have seriously depressed left ventricular function and 
thus, remain at risk of malignant arrhythmias even after 
successful catheter ablation of all inducible arrhythmias. 
Therefore, ablation is mostly used in an attempt to control 
refractory arrhythmias in patients with ICDs. Impaired left 
ventricular function also explains higher risk of complications 
such as stroke, myocardial infarction, heart block and/or 
perforation (approximately 5-8 %). Mortality risk may reach 
almost 3%.22
Arrhythmogenic right ventricular cardiomyopathy
Ventricular tachycardias associated with this clinical entity 
are re-entrant in origin and associated with fibrous and/or 
fibrofatty tissue in the right ventricle. Therefore, the typical 
ECG morphology is a LBBB configuration. Principally, the 
FIgURe 1. An example of a detailed electroanatomical voltage 
map (CARTO, Biosense Webster) of the left ventricle (A) in a 
patient with recurrent VT after previous anterior wall myocar-
dial infarction (right anterior oblique projection). Red colour 
identifies scar, grey zones represent dense scar without pacing 
capture. Two morphologies of VT were present (B) that shared 
the same critical isthmus between two dense scars with exits on 
opposite sides (see markers # and * in the map and correspond-
ing morphologies of VT with pacemaps from the exit site). Both 
VTs were successfully treated by a series of radiofrequency le-
sions between two dense scars (dark red dots).
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same techniques as in post-infarction VTs can be used to 
characterize the reentry circuit. Based on our experience, 
catheter ablation appears to be successful in long term con-
trol of stable VTs in the presence of more significant right 
ventricular scarring and nonsyncopal VTs.23
Non-ischemic cardiomyopathy
Mechanism of VTs in nonischemic cardiomyopathies var-
ies and includes scar-related reentry, focal origin and/or bundle 
branch reentry. This was emphasized in a study by Delacretaz 
et al24 who reported re-entrant VTs in 62%, ectopic VTs in 
27% and bundle branch reentry in 19% cases. Success rate 
reached 62 to 86%, according to the type of arrhythmia.
Previous surgery for congenital heart disease
Successful ablation of scar-related VTs after previous 
surgery for congenital heart disease has been reported anec-
dotally. Based on our own experience, re-entrant circuits can 
be identified accurately using electro-anatomical mapping. 
The obtained 3D map is then used as a guide for subsequent 
catheter ablation aiming at channels between dense scars in 
the right ventricle (Figure 2).
Bundle branch reentry
This specific arrhythmia accounts approximately for 5% 
of all monomorphic VTs in patients referred for electrophysi-
ologic studies.25 Reentrant circuit is composed of conduction 
system and transseptal intramyocardial conduction (Figure 
3). Excitation spreads anterogradely through the right bun-
dle branch, then transseptally to the left and retrogradely 
via the left bundle branch. Resulting ECG morphology is 
LBBB appearance with narrow rS complex contrasting with 
the enormous width of the whole QRS complex. Rarely, 
the impulse travels in opposite direction. This VT occurs 
predominantly in subjects with dilation of the heart and im-
paired intraventricular conduction (often LBBB pattern in 
sinus rhythm and prolonged HV interval). Catheter ablation 
is aimed at the right bundle and leaves this particular form of 
VT non-inducible. However, it can coexist with scar related 
VTs and many subjects will end up with an ICD even after 
successful ablation.
C O N C l U S I O N S
Catheter ablation may be considered as the first line 
treatment in all symptomatic idiopathic VTs, in recurrent 
VTs associated with structural heart disease and relatively 
preserved left ventricular ejection fraction (>35%) and/or 
bundle branch reentry VT.26 It is also preferable treatment 
modality in incessant VTs of any origin.
Catheter ablation appears to improve arrhythmia control 
FIgURe 2. Both activation (A) and voltage (B) map of the right ventricle viewed from posterior aspect (facing tricuspid annulus 
– TA) in a patient after radical surgery for tetralogy of Fallot. Maps show dense scars corresponding to ventricular patch (lower grey 
area) and to a patch after ventricular outflow tract repair (upper grey area). Activation map was obtained during clinical VT (C) and 
reveals propagation of the wavefront via narrow channel between both scars (arrows). Corresponding voltage map shows that the 
whole surrounding area is a scar with low voltage of the signal (red colour). VT was successfully treated by lesions placed within the 
narrow channel. Then, a line of block was created from this region to the tricuspid annulus (dark red dots) to prevent induction of 
other forms of VT.
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in about two thirds of patients with structural heart disease and 
mappable VTs. Novel substrate and/or noncontact mapping 
techniques suggest that even untolerated VTs and/or VTs of 
multiple morphologies can be successfully ablated.26-31 As the 
resulting noninducibility of VTs may not decrease the risk of 
dying suddenly in these patients with depressed left ventricular 
ejection fraction, the majority of patients with VT associated 
with structural heart disease remain recipients of ICD. On the 
other hand, catheter ablation is a method of choice in subjects 
with ICD and frequent arrhythmias.
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